| Defining a standard set of patient-centered outcomes for men with localized prostate cancer NE Martin, L Massey, C Stowell, C Bangma, A Briganti, A Bill-Axelson, ... European urology 67 (3), 460-467, 2015 | 262 | 2015 |
| Prostate cancer registries: current status and future directions G Gandaglia, F Bray, MR Cooperberg, RJ Karnes, MJ Leveridge, ... European urology 69 (6), 998-1012, 2016 | 77 | 2016 |
| Recurrent torsion after previous testicular fixation H Sells, KL Moretti, GD Burfield ANZ Journal of Surgery 72 (1), 46-48, 2002 | 53 | 2002 |
| Oral conjugated estrogen therapy for treatment of hemorrhagic cystitis J Miller, GD Burfield, KL Moretti The Journal of urology 151 (5), 1348-1350, 1994 | 51 | 1994 |
| Development of an international prostate cancer outcomes registry SM Evans, N Nag, D Roder, A Brooks, J L Millar, KL Moretti, D Pryor, ... BJU international 117, 60-67, 2016 | 41 | 2016 |
| Development of indicators to assess quality of care for prostate cancer N Nag, J Millar, ID Davis, S Costello, JB Duthie, S Mark, W Delprado, ... European urology focus 4 (1), 57-63, 2018 | 33 | 2018 |
| Men presenting with prostate‐specific antigen (PSA) values of over 100 ng/mL M Ang, B Rajcic, D Foreman, K Moretti, ME O'Callaghan BJU international 117, 68-75, 2016 | 33 | 2016 |
| Tools for predicting patient-reported outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity ME O'Callaghan, E Raymond, J Campbell, AD Vincent, K Beckmann, ... Prostate cancer and prostatic diseases 20 (4), 378-388, 2017 | 31 | 2017 |
| Optimum tools for predicting clinical outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity JM Campbell, E Raymond, ME O'Callaghan, AD Vincent, KR Beckmann, ... Clinical genitourinary cancer 15 (5), e827-e834, 2017 | 31 | 2017 |
| BMX handlebar T Sparnon, K Moretti, RP Sach Medical journal of Australia 2 (12-13), 587-589, 1982 | 30 | 1982 |
| A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the disease R Ruseckaite, K Beckmann, M O’Callaghan, D Roder, K Moretti, J Millar, ... BMC cancer 16, 1-11, 2016 | 25 | 2016 |
| Prostate-specific antigen (PSA) rate of decline post external beam radiotherapy predicts prostate cancer death Z Shi, CB Pinnock, S Kinsey-Trotman, M Borg, KL Moretti, S Walsh, ... Radiotherapy and Oncology 107 (2), 129-133, 2013 | 25 | 2013 |
| Localised prostate cancer in elderly men aged 80–89 years, findings from a population‐based registry S Vatandoust, G Kichenadasse, M O'Callaghan, AD Vincent, T Kopsaftis, ... BJU international 121, 48-54, 2018 | 24 | 2018 |
| Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer C Martini, JM Logan, A Sorvina, C Gordon, AR Beck, BSY Ung, ... Pathology 55 (1), 40-51, 2023 | 21 | 2023 |
| Development of quality indicators to monitor radiotherapy care for men with prostate cancer: a modified Delphi method E Tsiamis, J Millar, S Baxi, M Borg, P De Ieso, H Elsaleh, F Foroudi, ... Radiotherapy and Oncology 128 (2), 308-314, 2018 | 17 | 2018 |
| ISUP group 4–a homogenous group of prostate cancers? TC Lu, K Moretti, K Beckmann, P Cohen, M O’Callaghan Pathology & Oncology Research 24, 921-925, 2018 | 15 | 2018 |
| Patient-reported functional outcome measures and treatment choice for prostate cancer T Tiruye, M O’Callaghan, K Moretti, A Jay, B Higgs, K Santoro, T Boyle, ... BMC urology 22 (1), 169, 2022 | 14 | 2022 |
| Extent and predictors of grade upgrading and downgrading in an Australian cohort according to the new prostate cancer grade groupings K Beckmann, M O'Callaghan, A Vincent, P Cohen, M Borg, D Roder, ... Asian Journal of Urology 6 (4), 321-329, 2019 | 14 | 2019 |
| Patient-reported outcomes after radiation therapy in men with prostate cancer: a systematic review of prognostic tool accuracy and validity ME O'Callaghan, E Raymond, JM Campbell, AD Vincent, K Beckmann, ... International Journal of Radiation Oncology* Biology* Physics 98 (2), 318-337, 2017 | 14 | 2017 |
| Androgen deprivation therapy in unlikely to be effective for treatment of COVID-19 ME O'Callaghan, A Jay, G Kichenadasse, KL Moretti Annals of Oncology 31 (12), 1780, 2020 | 13 | 2020 |
